Phenylhydrazine

Phenylhydrazine

SCHEMBL5581958

CC(=O)C=O.NNc1ccccc1.NNc1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.58
CYP3A4 P08684 2/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
IDO1 P14902 1/20 0.58
CYP2C19 P33261 1/20 0.58
PTGS2 P35354 1/20 0.58
NAPRT Q6XQN6 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TSHR P16473 3/20 0.45
ALOX5 P09917 1/20 0.45
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TAAR1 Q96RJ0 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylhydrazine SCHEMBL1043907 0.87 TDP1 (0.64) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL10719045 0.87 CYP3A4 (0.70) TDP1CYP3A4LMNACYP1A2CYP2D6
Methylglyoxal SCHEMBL5582423 0.84 TP53 (0.46) TDP1TSHRNPC1RAB9AMAPT
Phenylhydrazine SCHEMBL11810983 0.82 TDP1 (0.70) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL11666654 0.82 TDP1 (0.70) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL10867769 0.82 IDO1 (0.78) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL27469514 0.80 CYP3A4 (0.74) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL19875575 0.80 IDO1 (0.74) TDP1CYP3A4LMNACYP1A2CYP2D6
Phenylhydrazine SCHEMBL16763414 0.79 TDP1 (0.82) TDP1CYP3A4LMNACYP1A2CYP2D6
Acetophenone SCHEMBL28186726 0.79 CYP1A2 (0.58) TDP1CYP3A4LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070065443-A1 Fructoseamine 3 kinase and the formation of collagen and elastin DYNAMIS THERAPEUTICS, INC. 2007-03-22 US disclosed
US-5661139-A FOR INHIBITING GLYCOSYLATION OF PROTEINS TO PREVENT DISCOLORATION OF THE TEETH ALTEON INC. (US) 1997-08-26 US disclosed
WO-1996040622-A1 BIS-(2-ARYL)HYDRAZONES AS INHIBITORS OF THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS ALTEON INC. (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070065443-A1 Fructoseamine 3 kinase and the formation of collagen and elastin FN3K, PDXK, COLGALT1 TDP1 1427/4885CYP3A4 4738/4885LMNA 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.